The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues
Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal...
Saved in:
Published in: | FEBS letters Vol. 500; no. 3; pp. 145 - 148 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
England
Elsevier B.V
06-07-2001
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin-II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P
1 and P
1′ positions on the rate of catalysis. With the exception of angiotensin-(1–8) (angiotensin-II), which is a relatively poor substrate for TPP-I, the rate of catalysis increases with increasing chain length.
K
cat/
K
m values increase 50-fold between angiotensin-(1–5) and angiotensin-(1–14). TPP-I shows little specificity for the nature of the amino acids in the P
1 and P
1′ positions,
K
cat/
K
m values varying only 5-fold for a range of substitutions. However, Pro or Lys in the P
1 position and Pro in the P
1′ positions are incompatible with TPP-I activity. These observations suggest that TPP-I is a non-specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation. |
---|---|
AbstractList | Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin-II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P1 and P1' positions on the rate of catalysis. With the exception of angiotensin-(1-8) (angiotensin-II), which is a relatively poor substrate for TPP-I, the rate of catalysis increases with increasing chain length. K(cat)/K(m) values increase 50-fold between angiotensin-(1-5) and angiotensin-(1-14). TPP-I shows little specificity for the nature of the amino acids in the P1 and P1' positions, K(cat)/K(m) values varying only 5-fold for a range of substitutions. However, Pro or Lys in the P1 position and Pro in the P1' positions are incompatible with TPP-I activity. These observations suggest that TPP-I is a non-specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation. Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP-I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin-II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P 1 and P 1′ positions on the rate of catalysis. With the exception of angiotensin-(1–8) (angiotensin-II), which is a relatively poor substrate for TPP-I, the rate of catalysis increases with increasing chain length. K cat/ K m values increase 50-fold between angiotensin-(1–5) and angiotensin-(1–14). TPP-I shows little specificity for the nature of the amino acids in the P 1 and P 1′ positions, K cat/ K m values varying only 5-fold for a range of substitutions. However, Pro or Lys in the P 1 position and Pro in the P 1′ positions are incompatible with TPP-I activity. These observations suggest that TPP-I is a non-specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation. Tripeptidyl peptidase‐I (TPP‐I) is a lysosomal peptidase which cleaves tripeptides from the N‐terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP‐I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin‐II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P1 and P1′ positions on the rate of catalysis. With the exception of angiotensin‐(1–8) (angiotensin‐II), which is a relatively poor substrate for TPP‐I, the rate of catalysis increases with increasing chain length. K cat/K m values increase 50‐fold between angiotensin‐(1–5) and angiotensin‐(1–14). TPP‐I shows little specificity for the nature of the amino acids in the P1 and P1′ positions, K cat/K m values varying only 5‐fold for a range of substitutions. However, Pro or Lys in the P1 position and Pro in the P1′ positions are incompatible with TPP‐I activity. These observations suggest that TPP‐I is a non‐specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation. Tripeptidyl peptidase‐I (TPP‐I) is a lysosomal peptidase which cleaves tripeptides from the N‐terminus of peptides. The function of the enzyme is unclear but its importance is demonstrated by the fact that mutations in TPP‐I are responsible for late infantile neuronal ceroid lipofuscinosis, a lethal lysosomal storage disease. As a step towards identifying its natural substrates, we have used a series of synthetic peptides, based on angiotensin‐II, to explore the effects of peptide chain length and the effects of amino acid substitutions at the P 1 and P 1 ′ positions on the rate of catalysis. With the exception of angiotensin‐(1–8) (angiotensin‐II), which is a relatively poor substrate for TPP‐I, the rate of catalysis increases with increasing chain length. K cat / K m values increase 50‐fold between angiotensin‐(1–5) and angiotensin‐(1–14). TPP‐I shows little specificity for the nature of the amino acids in the P 1 and P 1 ′ positions, K cat / K m values varying only 5‐fold for a range of substitutions. However, Pro or Lys in the P 1 position and Pro in the P 1 ′ positions are incompatible with TPP‐I activity. These observations suggest that TPP‐I is a non‐specific, but essential, peptidase involved in the latter stages of lysosomal protein degradation. |
Author | Warburton, Michael J Bernardini, Francesca |
Author_xml | – sequence: 1 givenname: Michael J surname: Warburton fullname: Warburton, Michael J email: mwarburt@sghms.ac.uk – sequence: 2 givenname: Francesca surname: Bernardini fullname: Bernardini, Francesca |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11445074$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkE1v1DAQhi3Uim4LPwHkE4JDWn8nOaFStXSlSj1QzpbXHhejJA62F5R_T7JZwREkS-OZeeed0XOOToY4AEJvKLmkhKqrL4RQUcm65e8J_UCYIk0lXqANbWpecaGaE7T5IzlD5zl_J3Pe0PYlOqNUCElqsUHh6RvgPIINPthQJhw97qYcc-xNh0sKI4wluKnD68dkqLbYQYHUhwEc3k04lIyNLSEOeH5meA6xwJDDUG23c2q6-LyH_AqdetNleH2MF-jr3e3TzX318Ph5e3P9UFnBlKi8bRTzO0E4kdRxaRxvmbLMSE9Ia7hkLYjaO6FaRneKCSVBOtbwuiXQeMkv0LvVd0zxx7y36D5kC11nBoj7rGs6c5DNIpSr0KaYcwKvxxR6kyZNiV4Y6wNjvQDUhOoDYy3mubfHBftdD-7v1BHqLLhfBb9CB9P_ueq720_s0FkahB7Ki9XH1QpmYj8DJJ1tgMGCCwls0S6Gf1z7Gxj3oWc |
CitedBy_id | crossref_primary_10_1016_j_bbrc_2004_04_142 crossref_primary_10_1007_s10048_005_0218_3 crossref_primary_10_1007_s10741_007_9078_2 crossref_primary_10_1093_jb_mvi110 crossref_primary_10_1007_s00018_010_0468_6 crossref_primary_10_1016_j_peptides_2016_01_009 crossref_primary_10_1111_j_1750_3639_2004_tb00501_x crossref_primary_10_1111_j_1750_3639_2004_tb00077_x crossref_primary_10_1074_jbc_M507336200 crossref_primary_10_1679_aohc_76_1 |
Cites_doi | 10.1074/jbc.M008562200 10.1016/S0014-5793(98)01683-4 10.1073/pnas.84.21.7508 10.1046/j.1471-4159.2000.0740287.x 10.1006/bbrc.2000.2207 10.1002/ajmg.1320420428 10.1210/endo-103-5-1794 10.1093/oxfordjournals.jbchem.a022781 10.1006/abbi.1993.1523 10.1074/jbc.270.26.15798 10.1111/j.1440-1681.1996.tb02817.x 10.1016/0006-291X(85)90571-6 10.1016/S0167-4838(98)00012-0 10.1007/978-1-4615-5833-0_6 10.1126/science.277.5333.1802 10.1016/S0021-9258(17)35951-3 |
ContentType | Journal Article |
Copyright | 2001 Federation of European Biochemical Societies FEBS Letters 500 (2001) 1873-3468 © 2015 Federation of European Biochemical Societies |
Copyright_xml | – notice: 2001 Federation of European Biochemical Societies – notice: FEBS Letters 500 (2001) 1873-3468 © 2015 Federation of European Biochemical Societies |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/S0014-5793(01)02608-4 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1873-3468 |
EndPage | 148 |
ExternalDocumentID | 10_1016_S0014_5793_01_02608_4 11445074 FEB2S0014579301026084 S0014579301026084 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K -~X .55 .~1 0R~ 0SF 1B1 1OC 1~. 1~5 24P 29H 2WC 33P 4.4 4G. 53G 5GY 5RE 5VS 6I. 7-5 71M 8P~ AABNK AACTN AAEDW AAESR AAFTH AAHHS AAIKJ AAJUZ AALRI AANLZ AAQFI AAQXK AASGY AAXRX AAXUO AAZKR ABBQC ABCUV ABEFU ABFNM ABFRF ABGSF ABHUG ABJNI ABLJU ABMAC ABQWH ABVKL ABXDB ABXGK ACAHQ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIUM ACMXC ACNCT ACPOU ACXBN ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADEZE ADIYS ADKYN ADMGS ADMUD ADOZA ADQTV ADUVX ADXAS ADZMN ADZOD AEEZP AEFWE AEGXH AEKER AENEX AEQDE AEQOU AEUQT AEUYR AEXQZ AFBPY AFFNX AFFPM AFGKR AFPWT AFVGU AFZJQ AGHFR AGJLS AGYEJ AHBTC AHPSJ AI. AIACR AIAGR AITUG AIURR AIWBW AJBDE AJRQY ALMA_UNASSIGNED_HOLDINGS AMRAJ AMYDB AZFZN AZVAB BAWUL BFHJK BMXJE C45 CBWCG CS3 DCZOG DIK DOVZS DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FUBAC G-Q GBLVA GI5 GX1 HVGLF HZ~ IHE IXB J1W KBYEO L7B LATKE LCYCR LEEKS LITHE LOXES LUTES LX3 LYRES M41 MEWTI MO0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N9A NCXOZ O-L O9- OK1 OVD OZT P-8 P-9 P2P P2W PC. Q38 R2- R9- RIG RNS ROL RPZ SCC SDF SDG SDP SEL SES SEW SFE SSZ SUPJJ SV3 TEORI TR2 UHB UNMZH VH1 WBKPD WH7 WIH WIJ WIK WIN WOHZO WXSBR X7M XFK Y6R YK3 ZA5 ZGI ZZTAW ~02 AAHBH ADVLN AITYG AKRWK ALUQN HGLYW CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4264-fc862fb403051d35ad3926c2a5f009a3529e47fd46921b62465e5d283790e8f53 |
IEDL.DBID | 33P |
ISSN | 0014-5793 |
IngestDate | Fri Aug 16 08:51:57 EDT 2024 Fri Nov 22 00:02:05 EST 2024 Sat Sep 28 08:37:00 EDT 2024 Sat Aug 24 00:48:51 EDT 2024 Fri Feb 23 02:33:16 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | TPP-I, tripeptidyl peptidase-I Tripeptidyl peptidase-I Lysosomal peptide degradation MALDI-TOF-MS, matrix-assisted laser desorption ionisation-time of flight-mass spectrometry Angiotensin-II NHMec, -methylcoumarylamide TFA, trifluoroacetic acid |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4264-fc862fb403051d35ad3926c2a5f009a3529e47fd46921b62465e5d283790e8f53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1016/S0014-5793(01)02608-4 |
PMID | 11445074 |
PQID | 71000585 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_71000585 crossref_primary_10_1016_S0014_5793_01_02608_4 pubmed_primary_11445074 wiley_primary_10_1016_S0014_5793_01_02608_4_FEB2S0014579301026084 elsevier_sciencedirect_doi_10_1016_S0014_5793_01_02608_4 |
PublicationCentury | 2000 |
PublicationDate | July 06, 2001 |
PublicationDateYYYYMMDD | 2001-07-06 |
PublicationDate_xml | – month: 07 year: 2001 text: July 06, 2001 day: 06 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | FEBS letters |
PublicationTitleAlternate | FEBS Lett |
PublicationYear | 2001 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Page, Fuller, Chambers, Warburton (BIB1) 1993; 307 Ezaki, Takeda-Ezaki, Oda, Kominami (BIB4) 2000; 268 Lin, Sohar, Lackland, Lobel (BIB7) 2001; 276 Mason, R.W. (1996) Biology of the Lysosome, in: Subcellular Biochemistry (Lloyd, J.B. and Mason, R.W., Eds.), Vol. 27, pp. 159–190, Plenum, New York. Sleat, Donnelly, Lackland, Liu, Sohar, Pullarkat, Lobel (BIB6) 1997; 277 Palmer, Fearnley, Walker, Hall, Lake, Wolfe, Haltia, Martinus, Jolly (BIB13) 1992; 42 Bernardini, F. and Warburton, M.J. (2001) Eur. J. Pediatr. Neurol., in press. Authier, Mort, Bell, Posner, Bergeron (BIB9) 1995; 270 Alves dos Santos, C.M., van Kerkhof, P. and Strous, G.J. (2001) J. Biol. Chem., in press. Doebbler, Divor, Ellis (BIB19) 1978; 103 Vines, Warburton (BIB11) 1999; 443 Thomas, Thekkumkara, Baker (BIB17) 1996; 3 Junaid, Wu, Pullarkat (BIB3) 2000; 74 Vines, Warburton (BIB2) 1998; 1384 Balow, Tomkinson, Ragnarsson, Zetterqvist (BIB20) 1986; 261 Tomkinson, Wernstedt, Hellman, Zetterquist (BIB8) 1987; 84 Boustany, R.-M. (1996) Neurodystrophies and neurolipidoses, in: Handbook of Clinical Neurology (Moser, H.W., Ed.), Vol. 22, pp. 671–700, Elsevier Science, Amsterdam. McDonald, Hoisington, Eisenbauer (BIB10) 1985; 126 Ezaki, Takeda-Ezaki, Kominami (BIB14) 2000; 128 Kargel, Dettmer, Etzold, Kirschke, Bohley, Titani (BIB21) 1981; 40 Rosche, F., Schmidt J., Hoffmann T., Pauly R.P., McIntosh C.H.S., Pederson R.A. and Demuth H.-U. (2000) in: Mass Spectrometry of Proteins and Peptides (Chapman, J.R., Ed.), pp. 251–272, Humana, Totowa, NJ. 2001; 276 1993; 307 1987; 84 2000; 268 2000; 128 2000; 74 1997; 277 1986; 261 1985; 126 1999; 443 1978; 103 1992; 42 1998; 1384 1996; 3 1981; 40 1995; 270 e_1_2_5_15_1 e_1_2_5_14_1 e_1_2_5_17_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 Kargel H.-J. (e_1_2_5_22_1) 1981; 40 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_21_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_20_1 |
References_xml | – volume: 84 start-page: 7508 year: 1987 end-page: 7512 ident: BIB8 publication-title: Proc. Natl. Acad. Sci. USA contributor: fullname: Zetterquist – volume: 126 start-page: 63 year: 1985 end-page: 71 ident: BIB10 publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Eisenbauer – volume: 276 start-page: 2249 year: 2001 end-page: 2255 ident: BIB7 publication-title: J. Biol. Chem. contributor: fullname: Lobel – volume: 103 start-page: 1794 year: 1978 end-page: 1804 ident: BIB19 publication-title: Endocrinology contributor: fullname: Ellis – volume: 40 start-page: 1139 year: 1981 end-page: 1143 ident: BIB21 publication-title: Acta Biol. Med. Ger. contributor: fullname: Titani – volume: 277 start-page: 1802 year: 1997 end-page: 1805 ident: BIB6 publication-title: Science contributor: fullname: Lobel – volume: 268 start-page: 904 year: 2000 end-page: 908 ident: BIB4 publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Kominami – volume: 443 start-page: 131 year: 1999 end-page: 135 ident: BIB11 publication-title: FEBS Lett. contributor: fullname: Warburton – volume: 307 start-page: 354 year: 1993 end-page: 359 ident: BIB1 publication-title: Arch. Biochem. Biophys. contributor: fullname: Warburton – volume: 42 start-page: 561 year: 1992 end-page: 567 ident: BIB13 publication-title: Am. J. Med. Genet. contributor: fullname: Jolly – volume: 1384 start-page: 233 year: 1998 end-page: 242 ident: BIB2 publication-title: Biochim. Biophys. Acta contributor: fullname: Warburton – volume: 261 start-page: 2409 year: 1986 end-page: 2417 ident: BIB20 publication-title: J. Biol. Chem. contributor: fullname: Zetterqvist – volume: 74 start-page: 287 year: 2000 end-page: 294 ident: BIB3 publication-title: J. Neurochem. contributor: fullname: Pullarkat – volume: 270 start-page: 15798 year: 1995 end-page: 15807 ident: BIB9 publication-title: J. Biol. Chem. contributor: fullname: Bergeron – volume: 128 start-page: 509 year: 2000 end-page: 516 ident: BIB14 publication-title: J. Biochem. contributor: fullname: Kominami – volume: 3 start-page: S74 year: 1996 end-page: 80 ident: BIB17 publication-title: Clin. Exp. Pharmacol. Physiol. contributor: fullname: Baker – volume: 277 start-page: 1802 year: 1997 end-page: 1805 publication-title: Science – volume: 307 start-page: 354 year: 1993 end-page: 359 publication-title: Arch. Biochem. Biophys. – volume: 3 start-page: S74 year: 1996 end-page: 80 publication-title: Clin. Exp. Pharmacol. Physiol. – volume: 40 start-page: 1139 year: 1981 end-page: 1143 publication-title: Acta Biol. Med. Ger. – volume: 74 start-page: 287 year: 2000 end-page: 294 publication-title: J. Neurochem. – volume: 443 start-page: 131 year: 1999 end-page: 135 publication-title: FEBS Lett. – volume: 103 start-page: 1794 year: 1978 end-page: 1804 publication-title: Endocrinology – volume: 84 start-page: 7508 year: 1987 end-page: 7512 publication-title: Proc. Natl. Acad. Sci. USA – volume: 268 start-page: 904 year: 2000 end-page: 908 publication-title: Biochem. Biophys. Res. Commun. – volume: 261 start-page: 2409 year: 1986 end-page: 2417 publication-title: J. Biol. Chem. – volume: 126 start-page: 63 year: 1985 end-page: 71 publication-title: Biochem. Biophys. Res. Commun. – volume: 128 start-page: 509 year: 2000 end-page: 516 publication-title: J. Biochem. – volume: 270 start-page: 15798 year: 1995 end-page: 15807 publication-title: J. Biol. Chem. – volume: 42 start-page: 561 year: 1992 end-page: 567 publication-title: Am. J. Med. Genet. – volume: 276 start-page: 2249 year: 2001 end-page: 2255 publication-title: J. Biol. Chem. – volume: 1384 start-page: 233 year: 1998 end-page: 242 publication-title: Biochim. Biophys. Acta – ident: e_1_2_5_8_1 doi: 10.1074/jbc.M008562200 – ident: e_1_2_5_12_1 doi: 10.1016/S0014-5793(98)01683-4 – ident: e_1_2_5_9_1 doi: 10.1073/pnas.84.21.7508 – ident: e_1_2_5_4_1 doi: 10.1046/j.1471-4159.2000.0740287.x – ident: e_1_2_5_16_1 – ident: e_1_2_5_5_1 doi: 10.1006/bbrc.2000.2207 – ident: e_1_2_5_13_1 – ident: e_1_2_5_14_1 doi: 10.1002/ajmg.1320420428 – ident: e_1_2_5_20_1 doi: 10.1210/endo-103-5-1794 – ident: e_1_2_5_15_1 doi: 10.1093/oxfordjournals.jbchem.a022781 – ident: e_1_2_5_2_1 doi: 10.1006/abbi.1993.1523 – ident: e_1_2_5_10_1 doi: 10.1074/jbc.270.26.15798 – ident: e_1_2_5_6_1 – ident: e_1_2_5_18_1 doi: 10.1111/j.1440-1681.1996.tb02817.x – ident: e_1_2_5_11_1 doi: 10.1016/0006-291X(85)90571-6 – ident: e_1_2_5_3_1 doi: 10.1016/S0167-4838(98)00012-0 – ident: e_1_2_5_17_1 doi: 10.1007/978-1-4615-5833-0_6 – ident: e_1_2_5_7_1 doi: 10.1126/science.277.5333.1802 – ident: e_1_2_5_19_1 – volume: 40 start-page: 1139 year: 1981 ident: e_1_2_5_22_1 publication-title: Acta Biol. Med. Ger. contributor: fullname: Kargel H.-J. – ident: e_1_2_5_21_1 doi: 10.1016/S0021-9258(17)35951-3 |
SSID | ssj0001819 |
Score | 1.7780572 |
Snippet | Tripeptidyl peptidase-I (TPP-I) is a lysosomal peptidase which cleaves tripeptides from the N-terminus of peptides. The function of the enzyme is unclear but... Tripeptidyl peptidase‐I (TPP‐I) is a lysosomal peptidase which cleaves tripeptides from the N‐terminus of peptides. The function of the enzyme is unclear but... |
SourceID | proquest crossref pubmed wiley elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 145 |
SubjectTerms | Amino Acid Substitution Aminopeptidases Angiotensin II - analogs & derivatives Angiotensin II - chemistry Angiotensin II - drug effects Angiotensin-II Animals Catalysis Chromatography, High Pressure Liquid Dipeptidyl-Peptidases and Tripeptidyl-Peptidases Endopeptidases - chemistry Endopeptidases - pharmacology Hydrogen-Ion Concentration Lysosomal peptide degradation Lysosomes - enzymology MALDI-TOF-MS, matrix-assisted laser desorption ionisation-time of flight-mass spectrometry Neuronal Ceroid-Lipofuscinoses - enzymology NHMec, -methylcoumarylamide Peptides - chemistry Peptides - drug effects Serine Proteases Structure-Activity Relationship Substrate Specificity - physiology Swine TFA, trifluoroacetic acid TPP-I, tripeptidyl peptidase-I Tripeptidyl peptidase-I |
Title | The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues |
URI | https://dx.doi.org/10.1016/S0014-5793(01)02608-4 https://onlinelibrary.wiley.com/doi/abs/10.1016%2FS0014-5793%2801%2902608-4 https://www.ncbi.nlm.nih.gov/pubmed/11445074 https://search.proquest.com/docview/71000585 |
Volume | 500 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSyQxEA6uIO7F566OzxxE9NBrv9KTPo46w4iwLKjgLaQ7iQw43WLPHObmT_A3-kusSrpnFJH1IPQh5EU6qSRfJVVfCDlIuOEyV6mnNF4zhkHu8TxNvUwpLlkURlGG3sj9q_bfW37eRZqcy8YXxvFDTA_ccGbY9RonuMyqN_rmFaJ7j7WRDYkj3XyK9FjcQ25Q0BqsO0f0b7oqw07moHBdaObNczKr6cgPjutaPtunPuLQ97DW7ku95W_9oxWyVMNT2nHytErmdLFG1jsFqObDCT2k1mDUnsSvkYXTJrR41jwbt06GIHgU_TfRBgkgPi0NvZ9UZVUOoeIRrFFoR6Mm99QFYBd9eXq-oKq2y9GKZhM6GFXUuVxQ-GRxNyitqX2BeS8gwp05Vb_ITa97fdb36jcdvByxl2dyUKFMFuM6E6iISQUALclDyQygPQlwMNVx2yjQ2sMgS8I4YZoppOhJfc0Ni36T-aIs9CahqQwSwwwgPsiuJJNJO8hAtGLDIxlxv0X-NCMoHhx1h5jZtEFXC-xq4QfCdrOIW4Q34yxq_OFwhYCx-l_R_UYuBPQ3XrrIQpfjSiB7kg86WYtsOHGZtQV0WUDjULZjpeJrjRS97mloUzABGQEhOt76hjq2yU9nYIf2kDtkfvQ41rvkR6XGe3YqvQLrjRY7 |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB71IVQutLQUFvrwASE4BPJy1jluy652xVIhtUjcLCe2q0rdBJHdw974CfzG_pLO2EkXhBA9VMrB8kuOPba_sWc-A7zOhBWq1HmgDV0zxlEZiDLPg0JroXgSJ0lB3sjj8_7ZN_FxSDQ5084XxvND3B240cxw6zVNcDqQ_k3hPCd4H_A-0SEJ4pvPiR9LBOk6bKYZCiY5dCRf7tZl3Ms8GG5Lrfx5PqyqehtG79pq_rVT_Y1E_wS2bmcabT_sP-3AkxahsoEXqaewZqpd2BtUqJ3PluwNczaj7jB-Fx6ddKGt0-7luD2YoewxcuEkMyRE-ay27HrZ1E09w4rnuEyRKY1eXjMfwI305uevCdOtaY7RrFiyq3nDvNcFw09Vl1e1s7avKO8EI_yxU_MMvo6GF6fjoH3WISgJfgW2RC3KFiktNZFOuNKI0bIyVtwi4FOICHOT9q1GxT2OiixOM264JpaePDTC8mQfNqq6Mi-A5SrKLLcI-jC7Vlxl_ahA6UqtSFQiwh6874ZQfvfsHXJl1oZdLamrZRhJ180y7YHoBlq2EMRDC4mD9b-ix51gSOxvundRlakXjSQCpRDVsh489_KyaguqswjIsezAicX9GilHw5PYpVACkQJidPryAeo4hq3xxeepnE7OPr2Cx97ejswjD2Bj_mNhDmG90YsjN69uAZs0GmM |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB4VqhYufUAf2xc-VFV7CE3iOOscF9gVKyqERCv1ZjmxXSGxCSK7h73xE_iN_JLO2AnbqqraA1IOll9y7LH9jT3zGeB9Lp3UlSkiY-maMU2qSFZFEZXGSC14ynlJ3siHp8Pj7_JgTDQ5R70vTOCHuD1wo5nh12ua4BfG_aJvnhK6j8SQ2JAk0c0XRI8lo2wN7mcIy4lIn_OT22UZt7KAhbtSK3eez6uqPsbJp66av21UfwLR33Gt35gmj-_0l57Aow6fslEQqKdwz9ZbsD2qUTefLdkH5i1G_VH8FjzY60Mb-_27cdswQ8lj5MBJRkiI8Vnj2PmybdpmhhXPcZEiQxqzPGchgNvozdX1lJnOMMcaVi7Z2bxlweeC4afrH2eNt7WvKe8UI8KhU_sMvk3GX_cPo-5Rh6gi8BW5CnUoV2a00CSGC20QoeVVqoVDuKcRDxY2GzqDanualHma5cIKQxw9RWylE_w5rNdNbV8CK3SSO-EQ8mF2o4XOh0mJspU5yTWX8QB2-xFUF4G7Q62M2rCrFXW1ihPlu1llA5D9OKsOgARgoXCs_lV0p5cLhf1Nty66ts2iVUSfFKNSNoAXQVxWbUFlFuE4lh15qfi_RqrJeC_1KZRAlIAYnb26gzp24OHJwUR9mR4fvYbNYGxHtpFvYH1-ubBvYa01i3d-Vv0E88MZCQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+specificity+of+lysosomal+tripeptidyl+peptidase-I+determined+by+its+action+on+angiotensin-II+analogues&rft.jtitle=FEBS+letters&rft.au=Warburton%2C+Michael+J&rft.au=Bernardini%2C+Francesca&rft.date=2001-07-06&rft.pub=Elsevier+B.V&rft.issn=0014-5793&rft.eissn=1873-3468&rft.volume=500&rft.issue=3&rft.spage=145&rft.epage=148&rft_id=info:doi/10.1016%2FS0014-5793%2801%2902608-4&rft.externalDocID=S0014579301026084 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-5793&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-5793&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-5793&client=summon |